Effect of pterostilbene on lipids and lipid profiles in streptozotocin-nicotinamide induced type 2 diabetes mellitus

Journal of Applied Biomedicine

Volumn 6, Issue 1, 2007, Pages 31-37

  Satheesh, Marudamuthu Amarnath ^a   Pari, Leelavinothan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Diabetes; Lipids; Pterostilbene Lipoproteins

Indexed keywords

ANTIDIABETIC AGENT; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINAMIDE; PHOSPHOLIPID; PTEROSTILBENE; STREPTOZOCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; LIPID LIVER LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RAT; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS;

EID: 45249105048     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2008.005     Document Type: Article

References (31)

1. Al-Shamaony L, Al-Khazraji SM, Twaij HA: Hypoglycaemic effect of Artemisia herba alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharmacol. 43:167-171, 1994.
2. Bishayee A, Chatterjee M: Hypolipidaemic and antiatherosclerotic effects of oral Gymnema sylvestre R. Br. Leaf extract in albino rats fed on a high fat diet. Phytother. Res. 7:118-120, 1993.
3. 32P into plasma phosphatidylcholine of diabetic rats. Indian J. Nucl. Med., 2:92-98, 1987.
4. Deedwania PC, Hunninghake DB, Bays H: Effects of lipid-altering treatment in diabetes mellitus and metabolic syndrome. Am. J. Cardiol. 93:18C-20C, 2004.
5. Duncan BD: Multiple range tests for correlated and heteroscedastic means. Biometrics 13:359-364, 1957.
6. Falholt K, Falholt W, Lund B: An easy colorimetric method for routine determination of free fatty acids in plasma. Clin. Chim. Acta 46:105-111, 1973.
7. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J. Biol. Chem. 66:375-400, 1925.
8. Folch J, Lees M, Solane SGH: A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509, 1957.
9. Fossati P, Lorenzo P: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28:2077-2080, 1982.
10. Fruchart JC, Duriez P: Anti-cholesterol agents, new therapeutic approaches. Ann. Pharm. Fr. 62:3-18, 2004.
11. Fruchart JC, Staels B, Duriez P: PPAR-alpha in lipid and lipoprotein metabolism, vascular inflammation and atherosclerosis. Prog. Exp. Cardiol. 8:3-16, 2003.
12. Gervois P, Torra IP, Fruchart JC, Staels B: Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med. 38:3-11, 2000.
13. Gilde AJ, Van Bilsen M: Peroxisome proliferator-activated receptors (PPARS): Regulators of gene expression in heart and skeletal muscle. Acta Physiol. Scand. 178:425-434, 2003.
14. Indian Council of Medical Research (ICMR). Collaborating centers, New Delhi, Flexible open trial of vijayasar in case of newly diagnosed non-insulin dependent diabetes mellitus. Indian J. Med. Res. 108:24-29, 1998.
15. Kanters SDJMN, Banga JD, Erkelens DW: Lipid-lowering therapy in diabetes mellitus. Neth. J. Med. 58:214-222, 2001.
16. Klimes I, Sebokova E, Gasperikova, D, Mitkova A, Kuklova S, Bohov P, Stanek J: Search for extra pancreatic effects of new oral hypoglycemic agent A-1466. 1: Oral glucose tolerance tests in normal and hereditary insulin resistant rats. Endocr. Regul. 32:115-123, 1998.
17. Manickam M, Ramanathan M, Jahromi MA, Chansouria JP, Ray AB: Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J. Nat. Prod. 60:609-610, 1997.
18. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224-229, 1998.
19. Maurya R, Singh R, Deepak M, Handa SS, Yadav PP, Mishra PK: Constituents of Pterocarpus marsupium: an ayurvedic crude drug. Phytochemistry 65:915-920, 2004.
20. Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P: Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol. Cell. Endocrinol. 175:57-66, 2001.
21. Pari L, Amarnath Satheesh M: Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin and nicotinamide induced diabetic rats. Life Sci. 79:641-645, 2006
22. Parving HH, Hommel E: Prognosis in diabetic nephropathy. Br. Med. J. 299:230-237, 1989.
23. Philipp B, Shapiro DJ: Improved methods for the assay and activation of 3-hydroxy-3-methyl glutaryl coenzyme A reductase. J. Lipid Res. 20:588-593, 1970.
24. Rimando AM, Nagmani R, Feller D R, Yokoyama W: Pterostilbene, a new agonist for the Peroxisome Proliferator-Activated Receptor α-isofonn, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J. Agric. Food Chem. 53:3403-3407, 2005.
25. Soon YY, Tan BKH: Evaluation of the hypoglycemic and antioxidant activities of Morinda officinalis in streptozotocin induced diabetes rats. Singapore Med. J. 43:77-85, 2000.
26. Suresh Babu P, Srinivasan: Hypolipidaemic action of Curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 166:169-175, 1997.
27. Trinder P: Determination of blood glucose using an oxidase peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22:158-161, 1969.
28. Warrier PK, Nambiar VPK, Ramankutty C: Indian Medicinal. Plants. Orient Longman Limited, Madras 1995, pp. 381-383.
29. WHO Library Cataloguing-in-Publication Data, Diabetes Action Now: An initiative of the World Health, Organization and the International Diabetes Federation, 2004.
30. Zilversmit DB, Davis AK: Micro determination of phospholipids by TCA precipitation. J. Lab. Clin. Med. 35:155-159, 1950.
31. Zlatkis,A, Zak B, Boyle GJ: A simple method for determination of serum cholesterol. J. Clin. Med. 41:486-492, 1953.